On the evening of May 25, Rejing Bio (688068, SH), Lepu Medical (300003, SZ), and Dean Diagnostics (300244, SZ) announced that the company’s monkeypox virus nucleic acid detection kit (PCR fluorescent probe Law) to obtain EU CE certification.
Two days ago, the monkeypox virus nucleic acid detection kit of Daan Gene (002030, SZ) also obtained the CE registration certificate.
This means that the products of 4 companies can be sold in EU countries and countries that recognize EU CE certification.
According to the World Health Organization (WHO), as of May 21, 12 non-monkeypox-endemic countries have reported 92 confirmed and 28 suspected cases of monkeypox to the organization, and global confirmed cases of monkeypox are expected to continue. Increase.
As related concepts are hot in the capital market, many companies including Rejing Bio, Daan Gene, Shuo Shi Bio (688399, SH), Shengxiang Bio (688289, SH), *ST Kehua (002022, SZ) A listed company has successively stated that it has reserved testing capabilities.
However, under the prediction that “the possibility of large-scale monkeypox infection is small” in the industry, there is still a question mark on the market demand for testing products. The above-mentioned four listed companies all stated in their announcements that the products are still in the market development stage, and there is uncertainty in the market demand.
The reporter also noted that on May 24, local time, the WHO stated that as more and more countries announced the implementation of small-scale vaccination programs to deal with the spread of monkeypox virus, for now, “non-endemic countries” outside Africa The spread of monkeypox virus is under control.
(Editor: Duan Jingyuan)
Keywords: